Menu

Image of the Day: Size Matters

The male proboscis monkey’s large nose probably evolved in response to female preference and competition between males.

Feb 23, 2018
The Scientist Staff, The Scientist Staff

A group of male, female, and juvenile proboscis monkeys (Nasalis larvatus)KYOTO UNIVERSITY / MATSUDA LAB

Proboscis monkeys (Nasalis larvatus) are named for the males’ large noses, and they appear to have evolved them to attract females, researchers reported Wednesday (February 21) in Science Advances.

These monkeys are the only primate species in which males have strikingly different noses than females. To test whether the trait evolved to attract females, researchers at Kyoto University compared body mass, testicular volume, harem size, and facial characteristics—including nose dimensions—of monkeys in captivity and in the wild. They found a link between nose size and the number of females in each male’s harem.

“We found [a] strong correlation between the size of an enlarged nose with physical strength, indicated by body mass, and reproductive ability, indicated by testis size,” says primatologist and study coauthor Hiroki Koda, in a statement. “The number of harem females was larger as well. To put it simply, the large nose appears to act as a ‘badge’ of strong male characteristics.”

H. Koda et al., “Nasalization by Nasalis larvatus: Larger noses audiovisually advertise conspecifics in proboscis monkeys,” Sci Adv, doi:10.1126/sciadv.aaq0250, 2018

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!